Basic Information

Drug ID DDPD08901 ...
Drug Name Ponatinib
Molecular Weight 532.5595
Molecular Formula C29H27F3N6O
CAS Number 943319-70-8
SMILES CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
External Links
DRUGBANK DB08901
PubChem Compound 24826799
PDR 3155
Drugs.com Drugs.com Drug Page

Experimental Physicochemical Property

Property Name Property Value Unit Raw Value Raw Unit Reference
pKa 5.285 - 2.77,7.8 - FDA label

Pharmacokinetic/ Toxicokinetic Property

Property Name Property Value Unit Raw Value Raw Unit Annotation Reference
AUC 1253.0 ng.h/ml 1253.0 ng.h/ml DRUGBANK
C Max 73.0 ng/ml 73 ng/ml DRUGBANK
T Max 6.0 h 6 h PO, oral; DRUGBANK
Metabolic 64.0 % 64 % DRUGBANK
Volume of Distribution 1223.0 L 1223.0 L Steady state volume of distribution; PO, oral; tumor; patients; DRUGBANK
Half-life 24.0 h 24(12-66) h elimination half-life; tumor; patients; Oral multiple dose; DRUGBANK
Eliminate Route 87.0 % ~87 % Faeces excretion; Oral single dose; DRUGBANK
Eliminate Route 5.0 % ~5 % Urinary excretion; DRUGBANK
Protein Binding 99.0 % >99 % plasma proteins; DRUGBANK

Maximum Dosage

Property Name Property Value Unit Raw Value Raw Unit Annotation Brand Name Component Reference
Max dose for adults 45.0 mg/day 45 mg/day PO, oral Iclusig ponatinib PDR
Max dose for adults 30.0 mg/day 30 mg/day PO, oral Iclusig ponatinib PDR
Max dose for geriatric 45.0 mg/day 45 mg/day PO, oral Iclusig ponatinib PDR
Max dose for geriatric 30.0 mg/day 30 mg/day PO, oral Iclusig ponatinib PDR

Drug Property Radar Chart

...

Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1